Clinical Trial Update: Study To Evaluate The Effect Of Torcetrapib/Atorvastatin In Subjects With A Genetic Cholesterol Disorder. [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating torcetrapib and atorvastatin in subjects with Hyperlipoproteinemia Type III has been terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperlipoproteinemia Type Iii

Drugs mentioned

• Torcetrapib (torcetrapib)
• atorvastatin (atorvastatin)

Snippet

Sponsor: Pfizer | Conditions: Hyperlipoproteinemia Type III | Phase 3 | Status: TERMINATED